Article Information
- Received May 13, 2005
- Revision received June 28, 2005
- Accepted June 29, 2005
- First published August 10, 2005.
- Version of record published August 10, 2005.
Author Information
- 1Center for Neurobiology and Behavior, 2Department of Biochemistry and Molecular Biophysics, and 3Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, and 4Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan 48109
Author contributions
Disclosures
- Received May 13, 2005.
- Revision received June 28, 2005.
- Accepted June 29, 2005.
C.A.G.M. and J.E.G. were supported by National Institute of Neurological Disorders and Stroke Grant NS-17125. B.G.N. was a Marion Abbe Fellow of the Damon Runyon Cancer Research Fund (DRG-1569). We thank Tom Jessell and Fiona Doetsch for insightful discussions and comments on this manuscript. We are grateful to Carol Mason for graciously sharing imaging equipment, Rachel Ventura for help with Olig2 expression analysis, and Michael Hack and Magdalena Gotz for sharing unpublished work. Finally, we thank Satoshi Suzuki and Ana Milosevic for providing expert assistance with retroviral production and stereotaxic injections.
Correspondence should be addressed to Dr. James E. Goldman, Division of Neuropathology, Department of Pathology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032. E-mail: Jeg5{at}columbia.edu.
Copyright © 2005 Society for Neuroscience 0270-6474/05/257289-10$15.00/0
Online Impact
